Company intelligence / Profile preview
Altus Formulation
Laval, Quebec, Canadaaltusformulation.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Altus Formulation develops value-added medicines using proprietary drug delivery technologies. Their lead programs leverage platforms like Flexitab for improved safety, compliance, and differentiation. Clinical results are primarily at the proof-of-concept or early clinical stage.
- Therapeutic areas
- PsychiatryEndocrinologyOphthalmologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Spektar Therapeutics / Spektus Pharma Inc.Regional licensing agreements with leading pharma companies worldwide via outlicensing model
Beyond the preview
Go deeper on Altus Formulation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altus Formulation.